Delivery Order 36F79720D0191-36C25026F0668

Veterans Integrated Service Network 10 issued a $6,932.00 delivery order to Cosette Pharmaceuticals, Inc. on May 19, 2026, under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) for VYLEESI (bremelanotide) 1.75MG/0.3ML autoinjectors. The FSS-61-IB is a GSA-administered Federal Supply Schedule contract vehicle enabling VA medical facilities to procure pre-negotiated pharmaceutical products. Place of performance is Bridgewater, NJ. The order is firm fixed price with an...

<p>Veterans Integrated Service Network 5 issued a delivery order to Cosette Pharmaceuticals, Inc. on July 10, 2026, with a ceiling value of $6,932.00 for VYLEESI 0.3 ml injection under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB).</p> <p>Place of performance is South Plainfield, NJ. The order is firm fixed price with an ultimate completion date of July 17, 2026. No set-aside was used.</p>

The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 20 (VISN 20) awarded a delivery order to Cosette Pharmaceuticals, Inc. for the supply of Bremelanotide (VYLEESI) 1.75mg/0.3ml autoinjectors with increased usage. The contract, valued at $33,647.00 and set for completion by December 19, 2026, was awarded on December 20, 2025 under a firm fixed-price arrangement with no set-aside designation. Cosette Pharmaceuticals, headquartered in South Plainfield, New Jersey, will...

This is a firm-fixed-price delivery order awarded by the Veterans Integrated Service Network 21 (VISN 21), a civilian agency under the U.S. Department of Veterans Affairs (VA), to Cosette Pharmaceuticals, Inc. The contract is for the supply of BREMELANOTIDE (VYLEESI) 1.75MG/0.3ML AUTOINJECTOR, a pharmaceutical product. The contract has a ceiling value of $3,364.70 and an ultimate completion date of June 14, 2025. Cosette Pharmaceuticals is a for-profit organization registered in SAM.gov since...

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on April 1, 2026, for yuvafem 10 mcg vaginal insert (8s) with a ceiling value of $1,285.80.</p> <p>Place of performance is Conshohocken, PA 19428. The order is firm fixed price, with ultimate completion on April 2, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency issued a $1,079.98 delivery order to Amerisourcebergen Drug Corp on May 6, 2026, for yuvafem 10 mcg vaginal insert (18 count).</p> <p>Place of performance is Conshohocken, PA. The order has a ceiling value of $1,079.98 and an ultimate completion date of May 7, 2026. Pricing is firm fixed price. No set-aside was used.</p>

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (18 count) with a contract ceiling value of $2,328.28. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing contract vehicle. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of...

<p>The Defense Logistics Agency issued a $1,690.05 delivery order to AmerisourceBergen Drug Corp on May 1, 2026, for Yuvafem 10 mcg vaginal inserts (18 units).</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of May 4, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency issued a $1,969.82 delivery order to AmerisourceBergen Drug Corp on February 18, 2026, for supply of Yuvafem 10 mcg vaginal insert (18-count).</p> <p>Place of performance is Conshohocken, PA. The order has a ceiling value of $1,969.82 with an ultimate completion date of February 19, 2026. The order uses firm fixed pricing and carries no set-aside designation.</p>

<p>The Defense Logistics Agency issued a $7,740.03 delivery order to Amerisourcebergen Drug Corp on May 13, 2026, for Yuvafem 10 MCG vaginal inserts (8-count).</p> <p>Place of performance is Conshohocken, PA. The order has a firm fixed-price structure with an ultimate completion date of May 14, 2026. No set-aside was used.</p>